eli lilly obstructive sleep apnea news

FDA, obstructive sleep apnea and Eli Lilly

FDA approves first medication for obstructive sleep apnea, which also promotes weight loss

The FDA approved a new drug treatment for obstructive sleep apnea that improves the condition through weight loss. Sleep expert Dr. Wendy Troxel discusses the impact of the new development.

ABC · 4d

FDA approves Eli Lilly’s obesity medication for obstructive sleep apnea

The FDA has expanded the approval of Eli Lilly’s obesity medication Zepbound to include treating moderate to severe obstructive sleep apnea for people with obesity.

Investopedia on MSN · 1d

Sleep Apnea Device Maker Stocks Slide on FDA Ruling for Eli Lilly's Zepbound

Key Takeaways Shares of ResMed and Inspire Medical Systems fell after the FDA approved Eli Lilly's weight-loss drug Zepbound to treat moderate-to-severe obstructive sleep apnea in adults with obesity.

Milwaukee Journal Sentinel4d

The Food and Drug Administration on Friday approved Eli Lilly's weight-loss drug Zepbound as a treatment for moderate-to-severe sleep apnea and obesity. Zepbound is the first medication ...

Eli Lilly Stock Is Rising Monday: What's Going On?

Eli Lilly and Company (NYSE: LLY) shares are trading higher Monday. The upward momentum in the stock comes after the FDA ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

FDA, obstructive sleep apnea and Eli Lilly

Trending now